Results 11 to 20 of about 3,088,438 (300)

Interleukin‐21 in autoimmune and inflammatory skin diseases [PDF]

open access: hybridEuropean Journal of Immunology, 2023
AbstractStudies on the role of interleukins (ILs) in autoimmune and inflammatory diseases allow for the better understanding of pathologic mechanisms of disease and reshaping of treatment modalities. The development of monoclonal antibodies targeting specific ILs or IL signaling pathways (i.e., anti‐IL‐17/IL‐23 in psoriasis or anti‐IL‐4/IL‐13 in atopic
Alberto Mesas‐Fernández   +5 more
semanticscholar   +4 more sources

Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls [PDF]

open access: yesDermatology Practical & Conceptual, 2021
Background: Pemphigus is a rare group of autoimmune blistering diseases with unknown etiology and unclear pathogenesis. Pemphigus vulgaris (PV) is the most common subtype, and is characterized by ulcerations or flaccid blisters on mucous membranes and on
Pegah Shahbazian   +7 more
doaj   +2 more sources

Biological Functions of Interleukin-21 and Its Role in Inflammation [PDF]

open access: goldThe Scientific World Journal, 2007
Interleukin-21 (IL-21), the most recently discovered CD132-dependent cytokine, is mainly produced by activated T lymphocytes, particularly the inflammatory Th17 subset, and is believed to be a key factor in the transition between innate and acquired ...
Martin Pelletier, Denis Girard
doaj   +2 more sources

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells. [PDF]

open access: goldPLoS ONE, 2015
Several factors support CLL cell survival in the microenvironment. Under different experimental conditions, IL21 can either induce apoptosis or promote CLL cell survival.
Loris De Cecco   +11 more
doaj   +3 more sources

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models

open access: yesOncoImmunology, 2018
Recent advances in cancer treatment with checkpoint blockade of receptors such as CTLA-4 and PD-1 have demonstrated that combinations of agents with complementary immunomodulatory effects have the potential to enhance antitumor activity as compared to ...
Katherine E. Lewis   +13 more
doaj   +2 more sources

Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis [PDF]

open access: yesScientific Reports
In a previous study, it has been shown that the population of Th17 lymphocytes was increased in patients with FMF. IL-21 and IL-23 play significant roles in the production and differentiation of Th17 cells.
Mutlu Hizal   +7 more
doaj   +2 more sources

Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer [PDF]

open access: yesCells, 2019
Pancreatic ductal adenocarcinoma (PDAC) displays a marked fibro-inflammatory microenvironment in which infiltrated immune cells fail to eliminate the tumor cells and often—rather paradoxically—promote tumor progression.
Alica Linnebacher   +11 more
doaj   +2 more sources

The Effect of Periodontitis on Expression of Interleukin-21: A Systematic Review

open access: yesInternational Journal of Inflammation, 2016
Purpose. Inflammation and tissue breakdown are led by an array of inflammatory destructive mediators associated with initiation and progression of inflammatory diseases like periodontitis.
Archana Mootha   +4 more
doaj   +2 more sources

The association of single nucleotide polymorphism of interleukin-21 gene and serum interleukin-21 levels with systemic lupus erythematosus

open access: yesEgyptian Journal of Medical Human Genetics, 2017
Background: Systemic lupus erythematosus (SLE) is a common autoimmune disorder which commonly results from the combined effects of a large number of genes.
Yasmin Mohamed Ahmed   +4 more
doaj   +4 more sources

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection. [PDF]

open access: yesPLoS ONE, 2019
IL-21 is the most recently discovered common gamma-chain cytokine that promotes persistent T-cell responses in chronic infections, autoimmunity and cancer.
Mithun Khattar   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy